About us

Corporate philosophy

Our company is committed to manufacturing high-quality pharmaceutical active ingredients that meet both the needs of our customers and the requirements of a sustainable future.

Our corporate philosophy is based on fundamental principles that form the foundation of our actions. We are convinced that these principles not only support our success, but also reflect the responsibility we carry towards our customers, employees, the environment and society as a whole.

We are committed to seven guiding principles: quality, products, customer orientation, sustainability, integrity and ethics, compliance, and employee engagement and occupational health and safety. These principles shape our objectives and define our daily actions.

These seven principles form the foundation of our actions and serve as a guide for all employees in achieving our shared mission and ensuring sustainable success. They are not only a firmly embedded part of our corporate culture but have also been symbolically reflected in our logo for decades.

Our long-standing successful partnerships with reputable pharmaceutical manufacturers confirm the value and consistency of this approach.

History

  • 1987

    Home Home

    Establishment of Peptido GmbH in Mandelbachtal, Saarland

  • Acquisition by KD Pharma and relocation to the current site in Bexbach, Saarland

    Home Home

    1989

  • 2000

    Ccw Ccw

    Management buy-out and independent management by the new owners

  • New management – Dr. Michael Fünfrocken and Dr. Uwe Wahren, with the ownership structure remaining unchanged

    Arrows-ccw Arrows-ccw

    2013

  • 2015/16

    Chart-area Chart-area

    Construction and commissioning of a new building for GMP production, including a separate new QC laboratory and administrative offices

  • Renovation and expansion of staff facilities and entrance area – introduction of a LIMS in the QC laboratory

    Chart-area Chart-area

    2018

  • 2021

    Chart-area Chart-area

    Planning of a new production building

  • Start of construction of the new production building, including a new R&D laboratory

    Chart-area Chart-area

    2023

  • 2025

    Chart-area Chart-area

    Completion of the new production building

Team – Management

Dr. Michael Fünfrocken

Dr. Michael Fünfrocken

CEO

Dr. Fünfrocken has been Managing Director at Peptido since April 2013. He also directly leads the Quality Control department and serves as coordinator and primary contact for all IT-related matters.

He has more than 20 years of leadership experience in international companies in the areas of quality control and IT, with a focus on software validation in GMP environments.
He holds a degree in chemistry and a PhD in organic chemistry from Saarland University in Saarbrücken.

Dr. Uwe Wahren

Dr. Uwe Wahren

CEO

Dr. Wahren has been Managing Director at Peptido since April 2013. He also directly leads the commercial department and the regulatory affairs unit responsible for our global API registrations.

He has more than 20 years of leadership experience in global sales and business development and has a documented record of success in revenue growth and project development.

Previously, he held senior positions in quality management (QP), project management, and research and development within the mid-sized API industry.
He holds a Master’s degree in chemistry and a PhD in organic chemistry from the University of Leipzig.